Walmart buys Israeli product review insight firm Aspectiva

México Noticias Noticias

Walmart buys Israeli product review insight firm Aspectiva
México Últimas Noticias,México Titulares
  • 📰 Reuters
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 97%

Walmart said on Tuesday it has acquired Aspectiva, an Israeli start-up whose tec...

FILE PHOTO: Shoppers walk from a Walmart store in Mexico City, August 15, 2012. REUTERS/Edgard Garrido

TEL AVIV - Walmart said on Tuesday it has acquired Aspectiva, an Israeli start-up whose technology analyses consumers’ product reviews to help shoppers make decisions.Aspectiva will join Walmart’s Store No 8, the incubation arm launched by the U.S. retailer in 2017 to find new commerce-related technologies.

Aspectiva has developed machine-learning techniques and natural language processing capabilities, “areas we believe will have profound impact on how customers will shop in the future,” Store No 8 principal Lori Flees said. Walmart also has a strategic investment in Team8, an Israeli cybersecurity start-up incubator, and launched a joint venture with Eko, an interactive media and technology company with offices in Tel Aviv and New York.

Aspectiva was founded in 2013 and has raised $4 million, led by Jerusalem Venture Partners. Other investors include Japanese venture capital firm Global Brain, Finnish retailer Union Five and LivePerson.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Reuters /  🏆 2. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Why buying Walmart stock over Amazon is a better bet nowOld-school retailer Walmart has several advantages over its fast-moving rival Amazon.com, writes Jeff Reeves.
Leer más »

Pharma giant Roche just bought biotech firm Spark, the maker of an $850,000 eye drugPharma giant Roche just bought biotech firm Spark, the maker of an $850,000 eye drugRoche is set to buy gene therapy firm Spark Therapeutics for about $4.8 billion. Spark's stock more than doubled in premarket trading.
Leer más »

Fed minutes; Glencore caps coal; Setback for WalmartFed minutes; Glencore caps coal; Setback for WalmartHere's what you need to know about the markets before you start your business day.
Leer más »



Render Time: 2025-03-06 21:43:35